MedDataX Logo

Insulin Sensitivity of the Brain in Pathogenesis of Diabetes Mellitus Type 2

NCT ID: NCT00638209

Last Updated: 2008-03-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to investigate whether insulin sensitivity of the human brain correlates with insulin sensitivity of the liver.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Physiology of Energy Homeostasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

I

Group Type ACTIVE_COMPARATOR

Human insulin

Intervention Type DRUG

P

Group Type PLACEBO_COMPARATOR

Saline

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Human insulin

Intervention Type DRUG

Saline

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-70 Risk factor(s) for type 2 diabetes (e.g. overweight, family history of diabetes)

Exclusion Criteria

* Type 2 diabetes pregnancy acute or chronic diseases
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

German Research Foundation

OTHER

Sponsor Role collaborator

University Hospital Tuebingen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University Hospital Tuebingen, Internal Medicine IV

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Tuebingen, Internal Medicine IV

Tübingen, , Germany

Site Status RECRUITING

University Hospital Tuebingen

Tübingen, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Andreas Fritsche, MD

Role: CONTACT

Phone: +49 7071 29 80590

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Andreas Fritsche

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EudraCT 2006-004734-32

Identifier Type: -

Identifier Source: secondary_id

KFO-114

Identifier Type: -

Identifier Source: secondary_id

MEG-KFO-2

Identifier Type: -

Identifier Source: org_study_id